Sun Pharma recalls generic blood pressure drug

Photo (c) Outline 205 - Getty Images

Around 36,000 bottles may contain impurities

Sun Pharmaceutical Industries, Inc. of Cranbury, N.J., is recalling 34,000 bottles of Diltiazem Hydrochloride extended-release capsules. The generic drug is used to treat high blood pressure and chest pain.

The company said it is recalling the drug because certain lots of the prescription drug failed impurity tests at a U.S. Food and Drug Administration (FDA) laboratory.

The recall includes:

  • Lot # HAC3120A: 6912 Bottles

  • Lot # HAC3121A: 6792 Bottles

  • Lot # HAC4460A: 6816 Bottles

  • Lot # HAD0365A: 6744 Bottles

  • Lot # HAD1452A: 6840 Bottles

The drugs were distributed throughout the U.S. and have expiration dates ranging from April 2023 to February 2024. 

Sun Pharma first announced the recall last month but this week upgraded it to Class 2, meaning the product “may cause” temporary health issues that, in rare cases, could be serious.

Take a Home Warranty Quiz. Get matched with an Authorized Partner.